Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine.
Date: July 21-22, 2003.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: Marriott Gaithersburg Washingtonian Center, 9751 Washingtonian Boulevard, Salons F&G, Gaithersburg, MD 20878.
Contact Person: Vassil St. Georgiev, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 2102, 6700-B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496-2550, email@example.com.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, Start Printed Page 41832and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: July 9, 2003.
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-17859 Filed 7-14-03; 8:45 am]
BILLING CODE 4140-01-M